Xenetic Biosciences, Inc. (XBIO)

NASDAQ: XBIO · IEX Real-Time Price · USD
3.770
-0.180 (-4.56%)
At close: Mar 28, 2024, 3:58 PM
3.750
-0.020 (-0.53%)
After-hours: Mar 28, 2024, 6:57 PM EDT

Total Valuation

XBIO has a market cap or net worth of $6.13 million. The enterprise value is -$2.85 million.

Market Cap 6.13M
Enterprise Value -2.85M

Important Dates

The last earnings date was Thursday, March 21, 2024, after market close.

Earnings Date Mar 21, 2024
Ex-Dividend Date n/a

Share Statistics

XBIO has 1.54 million shares outstanding. The number of shares has increased by 7.44% in one year.

Shares Outstanding 1.54M
Shares Change (YoY) +7.44%
Shares Change (QoQ) +0.40%
Owned by Insiders (%) 19.05%
Owned by Institutions (%) 1.10%
Float 1.25M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.41
Forward PS n/a
PB Ratio 0.63
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.84, with zero debt.

Current Ratio 11.84
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -36.40% and return on invested capital (ROIC) is -46.10%.

Return on Equity (ROE) -36.40%
Return on Assets (ROA) -33.70%
Return on Capital (ROIC) -46.10%
Revenue Per Employee $634,997
Profits Per Employee -$1.03M
Employee Count 4
Asset Turnover 0.21
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -14.30% in the last 52 weeks. The beta is 2.62, so XBIO's price volatility has been higher than the market average.

Beta (1Y) 2.62
52-Week Price Change -14.30%
50-Day Moving Average 3.86
200-Day Moving Average 3.80
Relative Strength Index (RSI) 44.06
Average Volume (30 Days) 5,386

Short Selling Information

The latest short interest is 2,209, so 0.14% of the outstanding shares have been sold short.

Short Interest 2,209
Short Previous Month 8,664
Short % of Shares Out 0.14%
Short % of Float 0.18%
Short Ratio (days to cover) 2.37

Income Statement

In the last 12 months, XBIO had revenue of $2.54 million and -$4.13 million in losses. Loss per share was -$2.71.

Revenue 2.54M
Gross Profit 2.54M
Operating Income -4.52M
Pretax Income -4.13M
Net Income -4.13M
EBITDA -4.13M
EBIT -4.13M
Loss Per Share -$2.71
Full Income Statement

Balance Sheet

The company has $8.98 million in cash and no debt, giving a net cash position of $8.98 million or $5.83 per share.

Cash & Cash Equivalents 8.98M
Total Debt n/a
Net Cash 8.98M
Net Cash Per Share $5.83
Equity / Book Value 9.80M
Book Value Per Share 6.36
Working Capital 8.78M
Full Balance Sheet

Cash Flow

Operating Cash Flow -4.11M
Capital Expenditures n/a
Free Cash Flow -4.11M
FCF Per Share -$2.69
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -177.79% and -162.78%.

Gross Margin 100.00%
Operating Margin -177.79%
Pretax Margin -162.78%
Profit Margin -162.78%
EBITDA Margin -162.78%
EBIT Margin -162.78%
FCF Margin -161.98%

Dividends & Yields

XBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.44%
Shareholder Yield -7.44%
Earnings Yield -67.43%
FCF Yield -67.10%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on May 15, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date May 15, 2023
Split Type Reverse
Split Ratio 1:10

Scores

XBIO has an Altman Z-Score of -21.02 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -21.02
Piotroski F-Score 2